Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria
Open Access
- 1 February 1997
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 3 (1) , 73-81
- https://doi.org/10.1111/j.1469-0691.1997.tb00254.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coliJournal of Antimicrobial Chemotherapy, 1994
- A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1993
- Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenemJournal of Antimicrobial Chemotherapy, 1993
- Postantibiotic and bactericidal effect of imipenem againstPseudomonas aeruginosaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- The carbapenems: new broad spectrum -lactam antibioticsJournal of Antimicrobial Chemotherapy, 1989
- In-vitro studies of meropenemJournal of Antimicrobial Chemotherapy, 1989
- ß-Lactamase stability of imipenemJournal of Antimicrobial Chemotherapy, 1986
- In-vitro antibacterial activity of imipenem compared with four other ß-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospitalJournal of Antimicrobial Chemotherapy, 1986
- Phenotypic Tolerance: The Search for β-Lactam Antibiotics That Kill Nongrowing BacteriaClinical Infectious Diseases, 1986
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981